Late onset hypogonadism, sexuality and fertility

References

• Agarwal, P., Oefelein, M. (2005). Testosterone replacement therapy after primary treatment for prostate cancer. The Journal of Urology, 173, 533–536.
   PubMed Web of Science ®Google Scholar
• Araujo, A.B., Esche, G.R., Kupelian, V., O'Donnell, A.B., Travison, T.G., Williams, R.E., et al (2007). Prevalence of symptomatic androgen deficiency in men. Journal of Clinical Endocrinology and Metabolism, 92, 4241–4247.
   PubMed Web of Science ®Google Scholar
• Bain, J. (2010). Testosterone and the aging male: To treat or not to treat? Maturitas, 66, 16–22.
   PubMed Web of Science ®Google Scholar
• Balon, R., Segraves, R.T. (2005). Handbook of sexual dysfunction. Medical psychiatry. Volume 30. Boca Raton, London: Taylor & Francis.
   Google Scholar
• Bhasin, S., Bremner, W.J. (1997). Emerging issues in androgen replacement therapy. The Journal of Clinical Endocrinology and Metabolism, 82, 3–8.
   PubMed Web of Science ®Google Scholar
• Botchorishvili, G., Matikainen, M.P., Lilja, H. (2009). Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer. Current Opinion in Urology, 19, 221–226.
   PubMed Web of Science ®Google Scholar
• Carani, C., Granata, A., Fustini, M., Marrama, P. (1996). Prolactin and testosterone: Their role in male sexual function. International Journal of Andrology, 19, 48–54.
   PubMedGoogle Scholar
• Christ-Crain, M., Mueller, B., Gasser, T., Kraenzlin, M., Trummler, M., Huber, P., et al (2004). Is there a clinical relevance of partial androgen deficiency of the aging male? The Journal of Urology, 172, 624–627.
   PubMed Web of Science ®Google Scholar
• Corona, G., Razzoli, E., Forti, G., Maggi, M. (2008). The use of phosphodiesterase 5 inhibitors with concomitant medications. Journal of Endocrinological Investigation, 31, 799–808.
   PubMed Web of Science ®Google Scholar
• Ebeling, P.R. (2010). Androgens and osteoporosis. Current Opinion in Endocrinology Diabetes and Obesity, 17, 284–292.
   PubMedGoogle Scholar
• Ebert, T., Jockenhovel, F., Morales, A., Shabsigh, R. (2005). The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel. European Urology, 47, 137–146.
   PubMed Web of Science ®Google Scholar
• Edelstein, D., Dobs, A., Basaria, S. (2006). Emerging drugs for hypogonadism. Expert Opinion on Emerging Drugs, 11, 685–707.
   PubMedGoogle Scholar
• Gooren, L.J. (2010). Androgens and male aging: Current evidence of safety and efficacy. Asian Journal of Andrology, 12, 136–151.
   PubMed Web of Science ®Google Scholar
• Gruenewald, D.A., Matsumoto, A.M. (2003). Testosterone supplementation therapy for older men: Potential benefits and risks. Journal of the American Geriatrics Society, 51, 101–115.
   PubMed Web of Science ®Google Scholar
• Hassan, M., Killick, S. (2003). Effect of male age on fertility: Evidence for the decline in male fertility with increasing age. Fertility and Sterility, 79, 1520–1527.
   PubMed Web of Science ®Google Scholar
• Heinemann, L.A.J., Zimmerman, T., Vermeulen, A., Thiel, C. (1999). A new ‘aging male’ symptoms (AMS) rating scale. Aging Male, 2, 105–114.
   Google Scholar
• Jannini, E.A., Carosa, E., Rossi, S., Di Sante, S., Sebastiani, G., Lenzi, A. (2007). Ageing and male sexuality. Minerva Ginecologica, 1, 35–41.
   Google Scholar
• Jones, T.H. (2008). Testosterone deficiency in men. Oxford: Oxford University Press.
   Google Scholar
• Kapoor, D., Malkin, C.J., Channer, K.S., Jones, T.H. (2005). Androgens, insulin resistance and vascular disease in men. Clinical Endocrinology, 63, 239–250.
   PubMed Web of Science ®Google Scholar
• Kaufman, J.M., Vermeulen, A. (1997). Declining gonadal function in elderly men. Bailliere's Clinical Endocrinology and Metabolism, 1, 289–309.
   Google Scholar
• Kell, J.S. (2010). Prostate-specific antigen tests and prostate cancer screening: An updatefor primary care physicians. Canadian Journal of Urology, (Suppl. 1), 18–25.
   PubMedGoogle Scholar
• Kelleher, S., Conway, A.J., Handelsman, D.J. (2004). Blood testosterone threshold for androgen deficiency symptoms. Journal of Clinical Endocrinology and Metabolism, 89, 3813–3817.
   PubMed Web of Science ®Google Scholar
• Kirby, R., Gould, D. (2005). Testosterone replacement therapy in hypogonadal men and prostate cancer risk. BJU International, 96, 471–472.
   PubMed Web of Science ®Google Scholar
• Kohler, T.S., Kim, J., Feia, K., Bodie, J., Johnson, N., Makhlouf, A., et al (2008). Prevalence of androgen deficiency in men with erectile dysfunction. Urology, 71, 693–697.
   PubMed Web of Science ®Google Scholar
• Kühnert, B., Nieschlag, E. (2004). Reproductive functions of the ageing male. Human Reproduction Update, 10, 327–339.
   PubMed Web of Science ®Google Scholar
• Martınez-Jabaloyas, J., Queipo-Zaragozáb, A., Rodríguez-Navarroa, R., Gil-Saloma, M., Chuan-Nuez, P. (2007). Relationship between the Saint Louis University ADAM questionnaire and sexual hormonal levels in a male outpatient population over 50 years of age. European Urology, 52, 1760–1767.
   PubMed Web of Science ®Google Scholar
• Matsumoto, A.M. (2002). Andropause: Clinical implications of the decline in serum testosterone levels with aging in men. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 57, 76–99.
   PubMed Web of Science ®Google Scholar
• McKinlay, J.D., Feldman, M.A. (1994). Age related variation in sexual activity and interest in normal men: Results of the Massachusetts male aging study. In A.J. Rossi (Ed), Sexuality across the life course. ( pp. 231–236). Chicago, IL: The University of Chicago Press.
   Google Scholar
• Morales, A., Johnston, B., Heaton, J.P., Lundie, M. (1997). Testosterone supplementation for hypogonadal impotence: Assessment of biochemical measures and therapeutic outcomes. Journal of Urology, 157, 849–854.
   PubMed Web of Science ®Google Scholar
• Morales, A., Lunenfeld, B. (2002). Investigation, treatment and monitoring of late-onset hypogonadism in males. The Aging Male, 5, 74–86.
   PubMedGoogle Scholar
• Morales, A., Schulman, C.C., Tostain, J., Wu, C.W. F. (2006). Testosterone deficiency syndrome (TDS) needs to be named appropriately – The importance of accurate terminology. European Urology, 50, 407–409.
   PubMed Web of Science ®Google Scholar
• Morales, A., Tenover, J.L. (2002). Androgen deficiency in the ageing male: When, who and how to investigate and treat. The Urologic Clinics of North America, 29, 975–982.
   PubMed Web of Science ®Google Scholar
• Morley, J., Charlton, E., Patrick, P., Kaiser, F.E., Cadeau, P., McCready, D., et al (2000). Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism, 49, 1239–1242.
   PubMed Web of Science ®Google Scholar
• Neaves, W.B., Johnson, L., Petty, C.S. (1987). Seminiferous tubules and daily sperm production in older adult men with varied numbers of Leydig cells. Biology of Reproduction, 36, 301–308.
   PubMed Web of Science ®Google Scholar
• Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., et al; International Society of Andrology (ISA); International Society for the Study of the Aging Male (ISSAM); European Association of Urology (EAU). (2005). Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. European Urology, 48, 1–4.
   PubMed Web of Science ®Google Scholar
• Park, N.C., Yan, B.Q., Chung, J.M., Lee, K.M. (2003). Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency. Aging Male, 6, 86–93.
   PubMedGoogle Scholar
• Rabih, A., Hijazi, L., Cunningham, G.R. (2005). Andropause: is androgen replacement therapy indicated for the aging male? Annual Review of Medicine, 56, 117–137.
   PubMed Web of Science ®Google Scholar
• Rhoden, E.L., Averbeck, M.A., Teloken, P.E. (2008). Androgen replacement in men undergoing treatment for prostate cancer. Journal of Sexual Medicine, 5, 2202–2208.
   PubMed Web of Science ®Google Scholar
• Rhoden, E.L., Morgentaler, A. (2003). Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia. The Journal of Urology, 170, 2348–2351.
   PubMed Web of Science ®Google Scholar
• Rolf, C., Behre, H.M., Nieschlag, E., (1996). Reproductive parameters of older compared to younger men of infertile couples. International Journal of Andrology, 19, 135–142.
   PubMedGoogle Scholar
• Roth, M.Y., Amory, J.K., Page, S.T. (2008). Treatment of male infertility secondary to morbid obesity. Nature clinical practice. Endocrinology and Metabolism, 4, 415–419.
   Google Scholar
• Schiavi, R.C., Schreiner-Engel, P., Mandeli, J., Schanzer, H., Cohen, E. (1990). Healthy aging and male sexual function. American Journal of Psychiatry, 147, 766–771.
   PubMed Web of Science ®Google Scholar
• Schiavi, R.C., Schreiner-Engel, P., White, D., Mandeli, J. (1991). The relationship between pituitary-gonadal function and sexual behavior in healthy aging men. Psychosomatic Medicine, 53, 363–374.
   PubMed Web of Science ®Google Scholar
• Schreiber, G., Ziemer, M. (2008). The aging male – Diagnosis and therapy of late-onset hypogonadism. Journal der Deutschen Dermatologischen Gesellschaft, 6, 273–280.
   PubMed Web of Science ®Google Scholar
• Shabsigh, R., Zakaria, L., Anastasiadis, A., Seidman, S. (2001). Sexual dysfunction and depression: Etiology, prevalence, and treatment. Current Urology Reports, 2, 463–467.
   PubMedGoogle Scholar
• Silber, S.J. (1991). Effect of age on male fertility. Seminars in Reproductive Endocrinology, 9, Number 3.
   Google Scholar
• Traish, A.M., Saad, F., Guay, A. (2009). The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. Journal of Andrology, 30, 23–32.
   PubMedGoogle Scholar
• Vermeulen, A., Kaufman, J.M. (2002). Diagnosis of hypogonadism in the ageing male. The Ageing Male, 5, 170–176.
   PubMedGoogle Scholar
• Wang, C., Nieschlag, E., Swerdloff, R., Behre, H.M., Hellstrom, W.J., Gooren, L.J., et al (2009a). ISA, ISSAM, EAU, EAA and ASA recommendations. Investigation, treatment and monitoring of late-onset hypogonadism in males. European Urology, 55, 121–130.
   PubMed Web of Science ®Google Scholar
• Wang, C., Nieschlag, E., Swerdloff, R., Behre, H.M., Hellstrom, W.J., Gooren, L.J., et al (2009b). ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males. The Aging Male, 12, 5–12.
   PubMed Web of Science ®Google Scholar
• Wang, C., Swerdloff, R.S., Iranmanesh, A., Dobs, A., Snyder, P.G., Cunningham, G., et al; Testosterone Gel Study Group. (2000). Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Journal Clinical Endocrinology and Metabolism, 85, 2839–2853.
   PubMed Web of Science ®Google Scholar
• Warne, D.W., Decosterd, G., Okada, H., Yano, Y., Koide, N., Howles, C.M. (2009). A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertility and Sterility, 92, 594–604. Available at: www. issam.ch/freetesto.htm [Last accessed 26 November 2009].
   PubMed Web of Science ®Google Scholar
• Zitzmann, M., Faber, S., Nieschlag, E. (2006). Association of specific symptoms and metabolic risks with serum testosterone in older men. Journal of Clinical Endocrinology and Metabolism, 91, 4335–4343.
   PubMed Web of Science ®Google Scholar